Article info

Download PDFPDF
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma

Authors

  1. Correspondence to Dr Marco Agostini, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy; m.agostini{at}unipd.it
View Full Text

Citation

D’Angelo E, Zanon C, Sensi F, et al
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma

Publication history

  • Received July 20, 2017
  • Revised August 8, 2017
  • Accepted August 9, 2017
  • First published September 4, 2017.
Online issue publication 
March 20, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.